ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0460

Lymphocyte Clonal Expansion Distinguishes Different Forms of Uveitis

Michael Paley1, Lynn Hassman1, Philip Ruzycki1, Ekaterina Esaulova1, Grace Paley1, Jennifer Laurent1, Luke Springer1, Lacey Feigl1, Maxim Artyomov1 and Wayne Yokoyama2, 1Washington University, Saint Louis, 2Washington University, St Louis, MO

Meeting: ACR Convergence 2020

Keywords: autoimmune diseases, B-Lymphocyte, Eye Disorders, immunology, T-Lymphocyte

  • Tweet
  • Email
  • Print
Session Information

Date: Friday, November 6, 2020

Title: Miscellaneous Rheumatic & Inflammatory Diseases I: Mechanisms of Disease (0459–0463)

Session Type: Abstract Session

Session Time: 10:00AM-10:50AM

Background/Purpose: Anterior uveitis is a form of ocular inflammation associated with rheumatologic disease and can be categorized as granulomatous or non-granulomatous. Whether different ocular manifestations are associated with distinct immune responses, however, remains unclear. Here, we evaluated lymphocyte clonal expansion in granulomatous and non-granulomatous uveitis to determine whether putative antigen-driven T or B cell responses distinguish clinical presentations of ocular inflammation.

Methods: We performed single cell RNA-sequencing (scRNAseq) to obtain an unbiased gene expression survey of aqueous and blood immune cells in subjects with different forms of uveitis. This analysis allowed quantification, cell type identification, and transcriptional profiling of individual lymphocytes within the inflamed eye as compared to cells in circulation, along with T cell receptor and B cell receptor sequencing to determine clonotype distribution.

Results: The majority of aqueous immune cells were CD4 T cells, with smaller contributions of CD8 T cells, B cells, NK cells, and myeloid cells. Analysis of clonal expansion in granulomatous uveitis revealed highly expanded lymphocyte clonotypes, but only in one T or B cell lineage. Coincident with the clonal expansion were transcriptional signatures of T cell receptor signaling and effector differentiation. In contrast, non-granulomatous uveitis was not associated with robust clonal expansion in any T or B cell lineage analyzed.

Conclusion: Here, these data suggest that the clinical presentation of uveitis may be the result of distinct pathogenic mechanisms, with granulomatous inflammation arising from a select few antigen-specific T or B cells. Furthermore, this extensive clonal expansion was seen in a different lymphocyte lineage for each individual, suggesting a distinct antigen-specific response in each patient and highlighting the potential to identify personalized therapeutic targets.


Disclosure: M. Paley, None; L. Hassman, None; P. Ruzycki, None; E. Esaulova, None; G. Paley, None; J. Laurent, None; L. Springer, None; L. Feigl, None; M. Artyomov, None; W. Yokoyama, None.

To cite this abstract in AMA style:

Paley M, Hassman L, Ruzycki P, Esaulova E, Paley G, Laurent J, Springer L, Feigl L, Artyomov M, Yokoyama W. Lymphocyte Clonal Expansion Distinguishes Different Forms of Uveitis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/lymphocyte-clonal-expansion-distinguishes-different-forms-of-uveitis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lymphocyte-clonal-expansion-distinguishes-different-forms-of-uveitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology